The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 20,528 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 264 | 22,236 | SH | SOLE | 22,236 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 22,383 | 1,168,802 | SH | SOLE | 1,168,802 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 97,042 | 8,244,896 | SH | SOLE | 8,244,896 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | NOTE 2.500% 2/0 | 014339AA3 | 23,197 | 25,000,000 | PRN | SOLE | 25,000,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 99,672 | 2,300,301 | SH | SOLE | 2,300,301 | 0 | 0 | ||
AMEDISYS INC | COM | 023436108 | 282 | 2,320 | SH | SOLE | 2,320 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 284,452 | 22,792,634 | SH | SOLE | 22,792,634 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 34,397 | 609,658 | SH | SOLE | 609,658 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 51,786 | 183,500 | SH | SOLE | 183,500 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 151,325 | 1,068,832 | SH | SOLE | 1,068,832 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 405,492 | 8,752,254 | SH | SOLE | 8,752,254 | 0 | 0 | ||
ARRAY BIOPHARMA INC | NOTE 2.625%12/0 | 04269XAB1 | 50,155 | 16,500,000 | PRN | SOLE | 16,500,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 92,524 | 4,600,917 | SH | SOLE | 4,600,917 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 21,483 | 1,140,306 | SH | SOLE | 1,140,306 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 112,526 | 2,972,167 | SH | SOLE | 2,972,167 | 0 | 0 | ||
AVEDRO INC | COM | 05355N109 | 4,246 | 216,200 | SH | SOLE | 216,200 | 0 | 0 | ||
AXONICS MODULATION TECH INC | COM | 05465P101 | 33,329 | 813,500 | SH | SOLE | 813,500 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 4,946 | 39,900 | SH | SOLE | 39,900 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,324 | 97,191 | SH | SOLE | 97,191 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,565 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 75,707 | 1,669,400 | SH | SOLE | 1,669,400 | 0 | 0 | ||
CASTLIGHT HEALTH INC | CL B | 14862Q100 | 33 | 10,229 | SH | SOLE | 10,229 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 51,489 | 557,000 | SH | SOLE | 557,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 36,229 | 690,870 | SH | SOLE | 690,870 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 15,372 | 3,558,388 | SH | SOLE | 3,558,388 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 51,484 | 3,462,300 | SH | SOLE | 3,462,300 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 22,471 | 3,138,365 | SH | SOLE | 3,138,365 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 50,137 | 2,223,376 | SH | SOLE | 2,223,376 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 25,787 | 172,100 | SH | SOLE | 172,100 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 76,518 | 888,705 | SH | SOLE | 888,705 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 27,301 | 878,403 | SH | SOLE | 878,403 | 0 | 0 | ||
ENDOLOGIX INC | COM NEW | 29266S304 | 570 | 78,755 | SH | SOLE | 78,755 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 109,551 | 8,729,142 | SH | SOLE | 8,729,142 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 220 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 210,301 | 10,359,666 | SH | SOLE | 10,359,666 | 0 | 0 | ||
FLEXION THERAPEUTICS INC | COM | 33938J106 | 266 | 21,630 | SH | SOLE | 21,630 | 0 | 0 | ||
FORTY SEVEN INC | COM | 34983P104 | 2,480 | 234,000 | SH | SOLE | 234,000 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 8,975 | 292,734 | SH | SOLE | 292,734 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 9,889 | 188,000 | SH | SOLE | 188,000 | 0 | 0 | ||
GLYCOMIMETICS INC | COM | 38000Q102 | 23,941 | 2,008,447 | SH | SOLE | 2,008,447 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 5,514 | 248,600 | SH | SOLE | 248,600 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 35,826 | 3,215,994 | SH | SOLE | 3,215,994 | 0 | 0 | ||
HOOKIPA PHARMA INC | COM | 43906K100 | 12,732 | 1,891,879 | SH | SOLE | 1,891,879 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB LTD | SHS | G46188101 | 274 | 11,400 | SH | SOLE | 11,400 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 30,282 | 13,954,794 | SH | SOLE | 13,954,794 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 8,821 | 375,375 | SH | SOLE | 375,375 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 24,005 | 168,387 | SH | SOLE | 168,387 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 1,260 | 254,590 | SH | SOLE | 254,590 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 43,504 | 1,080,300 | SH | SOLE | 1,080,300 | 0 | 0 | ||
LHC GROUP INC | COM | 50187A107 | 259 | 2,166 | SH | SOLE | 2,166 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 30,510 | 423,987 | SH | SOLE | 423,987 | 0 | 0 | ||
LOGICBIO THERAPEUTICS INC | COM | 54142F102 | 10,594 | 814,898 | SH | SOLE | 814,898 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 17,711 | 733,699 | SH | SOLE | 733,699 | 0 | 0 | ||
MYOKARDIA INC | COM | 62857M105 | 313 | 6,252 | SH | SOLE | 6,252 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 231 | 2,740 | SH | SOLE | 2,740 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 220 | 3,400 | SH | SOLE | 3,400 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 27,175 | 740,671 | SH | SOLE | 740,671 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 1,364 | 737,550 | SH | SOLE | 737,550 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 24,720 | 1,796,477 | SH | SOLE | 1,796,477 | 0 | 0 | ||
PERSONALIS INC | COM | 71535D106 | 10,860 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 8,102 | 244,100 | SH | SOLE | 244,100 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 71,475 | 1,391,376 | SH | SOLE | 1,391,376 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 32,208 | 2,197,003 | SH | SOLE | 2,197,003 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 62,603 | 412,000 | SH | SOLE | 412,000 | 0 | 0 | ||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 46,317 | 2,920,389 | SH | SOLE | 2,920,389 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 29,806 | 1,021,808 | SH | SOLE | 1,021,808 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 33,525 | 3,620,376 | SH | SOLE | 3,620,376 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 75,232 | 1,166,032 | SH | SOLE | 1,166,032 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 25,747 | 1,799,216 | SH | SOLE | 1,799,216 | 0 | 0 | ||
TELADOC HEALTH INC | COM | 87918A105 | 30,673 | 461,880 | SH | SOLE | 461,880 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 76,758 | 1,945,200 | SH | SOLE | 1,945,200 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 130,473 | 1,669,525 | SH | SOLE | 1,669,525 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 34,625 | 141,901 | SH | SOLE | 141,901 | 0 | 0 | ||
VAPOTHERM INC | COM | 922107107 | 22,069 | 959,539 | SH | SOLE | 959,539 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 316 | 16,720 | SH | SOLE | 16,720 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 135 | 16,260 | SH | SOLE | 16,260 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 70,957 | 2,719,707 | SH | SOLE | 2,719,707 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS | N96617118 | 70,738 | 2,372,157 | SH | SOLE | 2,372,157 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 66,012 | 1,612,798 | SH | SOLE | 1,612,798 | 0 | 0 | ||
XERIS PHARMACEUTICALS INC | COM | 98422L107 | 34,327 | 3,000,641 | SH | SOLE | 3,000,641 | 0 | 0 |